Targeting a Genetic Mutation Associated with Canine Bladder Cancer
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.
Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.
Researchers will assess how well specific chemotherapy drugs work as an adjunct therapy for dogs recovering from bone cancer surgery.
Researchers will investigate the efficacy of a new pain relief option, the transdermal lidocaine patch, for dogs that undergo surgery.
Researchers will investigate how Staphylococcus pseudintermedius, a common cause of bacterial skin and postoperative infections in dogs, forms groups of bacteria that stick to surfaces, such as catheters and orthopedic metal implants, making infections difficult to treat.
By studying how platelets and bacteria interact when dogs with serious infections develop blood poisoning, the research fellow will gain information that will improve treatment.
Researchers will investigate the role of a signaling pathway in the progression of bone cancer in dogs and evaluate its potential as a new therapeutic target to help treat this disease.
Researchers will determine whether the fur of animal-assistance therapy dogs can become contaminated with hospital-associated infections and test whether low-costinterventions can reduce the risk of microbial transmission between therapy animals and patients with childhood cancer.